EBR vs NSB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EBR

EBR SYSTEM CDI FORUS [EBR]

45LOW

NSB

NEUROSCIEN FPO [NSB]

49LOW

Score Breakdown

EBR NSB
Technical
47
49
Catalyst
55
53
Sentiment
50
50
Fundamental
42
87
Momentum
23
36
Risk Gate
42
46

Key Metrics

EBR Metric NSB
$175.7MMarket Cap$27.7M
2.8MAvg Volume (20d)301K
+0.1%Short InterestN/A
$1.47552-Week High$0.260
$0.36552-Week Low$0.055
-2.6%Daily Change-4.2%
$0.380Reference Price$0.068
-458.8%ROE-29.6%
N/AProfit MarginN/A

Active Signals

EBR Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Drifting lower — down 3.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (2.0 quarters)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

NSB Signals

Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (18 quarters)
Very high P/S ratio (87.0x)
Strong revenue growth (+129%)

Ask Scout AI to compare EBR and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EBR vs NTI →EBR vs NUZ →EBR vs NXN →EBR vs PAR →EBR vs PCK →
EBR Full Analysis → NSB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).